Apella Capital, LLC Amgen Inc Transaction History

Apella Capital, LLC

$2.41 Billion
Q3 2024

A detailed history of Apella Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Apella Capital, LLC holds 1,282 shares of AMGN stock, worth $409,701. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,282

Previous 1,228 4.4%

Holding current value

$409,701

Previous $383,000 7.83%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$309.38 - $337.38 $16,706 - $18,218	54 Added 4.4%	1,282 $413,000
Q2 2024 Jul 10, 2024	BUY	$262.75 - $319.31 $11,823 - $14,368	45 Added 3.8%	1,228 $383,000
Q1 2024 Apr 10, 2024	SELL	$268.87 - $324.56 $23,391 - $28,236	-87 Reduced 6.85%	1,183 $336,000
Q4 2023 Jan 05, 2024	SELL	$255.7 - $288.46 $153,931 - $173,652	-602 Reduced 32.16%	1,270 $365,000
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $131,190 - $162,876	600 Added 47.17%	1,872 $503,000
Q2 2023 Jul 06, 2023	SELL	$214.27 - $253.37 $8,142 - $9,628	-38 Reduced 2.9%	1,272 $282,000
Q4 2022 Jan 10, 2023	BUY	$229.03 - $291.01 $35,728 - $45,397	156 Added 13.52%	1,310 $0
Q3 2022 Oct 11, 2022	BUY	$224.46 - $253.15 $8,305 - $9,366	37 Added 3.31%	1,154 $260,000
Q2 2022 Jul 08, 2022	BUY	$230.71 - $256.74 $257,703 - $286,778	1,117 New	1,117 $272,000
Q3 2021 Oct 12, 2021	SELL	$212.27 - $248.7 $221,822 - $259,891	-1,045 Closed	0 $0
Q2 2021 Jan 18, 2022	SELL	$233.58 - $259.14 $700 - $777	-3 Reduced 0.29%	1,045 $255,000
Q2 2021 Jul 02, 2021	BUY	$233.58 - $259.14 $1,401 - $1,554	6 Added 0.58%	1,048 $255,000
Q1 2021 Apr 15, 2021	BUY	$221.91 - $258.6 $665 - $775	3 Added 0.29%	1,042 $259,000
Q4 2020 Feb 18, 2021	SELL	$216.38 - $257.67 $92,394 - $110,025	-427 Reduced 29.13%	1,039 $239,000
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $267,163 - $354,332	1,466 New	1,466 $297,000

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apella Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apella Capital, LLC with notifications on news.

Account

Apella Capital, LLC Amgen Inc Transaction History